Medicover AB (MCOV.B) Stock Statistics & Valuation Metrics

Medicover AB has a market cap or net worth of kr31.93B. The enterprise value is kr4.39B.

Medicover AB has 74,428,720 shares outstanding. The number of shares has decreased by -2.65% in one year.

Medicover AB’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is 5.59%.

The current PE Ratio of Medicover AB is 37.2. Medicover AB’s PEG ratio is 0.11.

In the last 12 months, Medicover AB had revenue of 2.38B and earned 77.50M in profits. Earnings per share was 0.51.

In the last 12 months, operating cash flow was 334.08M and capital expenditures -159.40M, giving a free cash flow of 174.69M billion.

Medicover AB pays an annual dividend of kr1.448, resulting in a dividend yield of 0.66%

Medicover AB upcoming earnings date is Apr 29, 2026, Before Open (Confirmed).

Medicover AB as a current ratio of 0.70, with Debt / Equity ratio of 270.23%

In the past 12 months, Medicover AB has paid 25.70M in taxes.

Medicover AB EV to EBITDA ratio is 11.69, with an EV/FCF ratio of 23.79.

Medicover AB has kr88.20M in cash and marketable securities with kr1.44B in debt, giving a net cash position of -kr1.35B billion.

Gross margin is 23.16%, with operating margin of 6.55%, and net profit margin of 3.26%.

The average price target for Medicover AB is ―, which is 11.43% higher than the current price. The consensus rating is ―